DURANEST Drug Patent Profile
✉ Email this page to a colleague
When do Duranest patents expire, and what generic alternatives are available?
Duranest is a drug marketed by Astrazeneca and Dentsply Pharm and is included in two NDAs.
The generic ingredient in DURANEST is etidocaine hydrochloride. Additional details are available on the etidocaine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DURANEST?
- What are the global sales for DURANEST?
- What is Average Wholesale Price for DURANEST?
Summary for DURANEST
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 33 |
Patent Applications: | 4,522 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DURANEST at DailyMed |
![DURANEST drug patent expirations Drug patent expirations by year for DURANEST](/p/graph/s/t/DURANEST-patent-expirations.png)
US Patents and Regulatory Information for DURANEST
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Astrazeneca | DURANEST | epinephrine; etidocaine hydrochloride | INJECTABLE;INJECTION | 017751-004 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Astrazeneca | DURANEST | etidocaine hydrochloride | INJECTABLE;INJECTION | 017751-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Astrazeneca | DURANEST | epinephrine bitartrate; etidocaine hydrochloride | INJECTABLE;INJECTION | 017751-006 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for DURANEST
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Astrazeneca | DURANEST | epinephrine bitartrate; etidocaine hydrochloride | INJECTABLE;INJECTION | 017751-007 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Astrazeneca | DURANEST | epinephrine; etidocaine hydrochloride | INJECTABLE;INJECTION | 017751-004 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Astrazeneca | DURANEST | etidocaine hydrochloride | INJECTABLE;INJECTION | 017751-005 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for DURANEST
See the table below for patents covering DURANEST around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | H0128006 | ⤷ Sign Up | |
United Kingdom | 1369259 | ⤷ Sign Up | |
Japan | S5644063 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |